A series of 4-benzyl/phenyl-3-(1-methyl-1 H -indole-2-yl)-1 H -1,2,4-triazole-5(4 H)-thione (4a,b) and 2-{4- [benzyl/phenyl-5-(substitutedbenzylthio)]-4 H -1,2,4-triazole-3-yl}-1-methyl-1 H -indole derivatives (5a-p) were synthesized and evaluated for their in vitro scavenging of DPPH and superoxide radical, and lipid peroxidation inhibition effects as well as their antimicrobial properties. DPPH radical scavenging capacity was found to be equipotent with BHT and found in compounds containing 1,2,4-triazole-5(4 H) -thione moiety (4a,b). With regard to antimicrobial properties, compound 5k showed slight antimicrobial activity against all the test microorganisms.
Introduction
Exogenous chemicals in food systems and endogenous metabolic processes in the human body produce highly reactive free radicals, particularly oxygen-derived free radicals. Reactive oxygen species (ROS) is a collective term that describes the chemical species that are formed upon incomplete reduction of oxygen and includes the superoxide anion (O
•−
2 ), hydrogen peroxide (H 2 O 2 ), and the hydroxyl radical (HO). ROS are constantly generated in the human body and are involved in various physiologically important biological reactions.
1−3
Under physiological conditions, there is a balance between the production of reactive oxygen and a biological system's ability to detoxify the reactive intermediates. Oxidative stress occurs when the generation of ROS in a system exceeds the system's ability to eliminate them. Excessive generation of ROS induced by various stimuli leads to a variety of pathophysiological abnormalities such as inflammation, diabetes, genotoxicity, and cancer. 4−6 Treatment with antioxidants seemed to be a promising therapeutic approach for these conditions.
Antioxidants interact with and stabilize free radicals and may prevent some of the damage free radicals might otherwise cause. Therefore, in recent years there has been a growing interest in developing new and efficient antioxidant compounds.
7,8
Indoles are very common in the body and the diet, and synthetic and natural products containing indole moieties are an important class of therapeutic agents. 9, 10 In recent decades, antioxidant activity of synthetic indole derivatives and their possible activity mechanisms have been studied. Indole structure, especially substitution of 2-position of indole, influences the antioxidant efficacy in biological systems.
11 N -Substituted indole-2/3-carboxamide and also ester derivatives show potent antioxidant activity against superoxide radical.
12−14
Inhibitory effect on lipid peroxidation of 2-phenyl indole derivatives was found as potent as butylatedhydroxytoluene (BHT) and compounds bearing electron-withdrawing groups showed the highest reduction in lipid peroxidation values. Triazole-containing indole derivatives showed protective activity against the oxidative injury of the ischemic myocardium and they scavenged superoxide anion and hydroxyl radical.
24
At the beginning of the twentieth century, infectious diseases were the leading cause of death worldwide. However, not only the emergence of new sources of infection but also developing resistance to antibiotics of existing infectious pathogens caused difficulties in the treatment of these diseases. 25 New antibacterial agents to treat infections caused by these gram-positive bacteria have recently been introduced, including the semisynthetic streptogramins quinupristin/dalfopristin, daptomycin, the synthetic oxazolidinone linezolid and tigecycline. Moreover, indole-substituted 2,5-dihydro-1H -2,5-pyrrolediones were found to have antibacterial activity against resistant strains of Mycobacterium smegmatis, S. aureus, and some other gram-positive bacteria. It was found that the activity of compounds against S. aureus and M. smegmatis improves with increasing hydrophobic properties as well as with hydrogen bond acceptors, depending on their distance from the indole-2-position.
31
Ethyl 6-bromo-5-hydroxy-1H -indole-3-carboxylate derivatives display a variety of biological effects, such as antiviral effect, immunostimulative effect, and interferon-induced activity. In support of these findings, ethyl 1H-indole-3-carboxylate derivatives were examined for their anti-HCV activities and found to be promising leads.
32
The 1,2,4-triazole and its derivatives were reported to exhibit various pharmacological activities such as antimicrobial, analgesic, anti-inflammatory, anticancer, and antioxidant properties. 33, 34 Some of the present day drugs such as ribavirin (antiviral agent), rizatriptan (antimigraine agent), alprazolam (anxiolytic agent), fluconazole, terconazole, and itraconazole (antifungal agents) are the best examples of potent molecules possessing a triazole nucleus (Figure 1 ). 35 Compounds containing indole and 1,2,4-triazole moieties as hybrid molecules including different pharmacophores were found to have antibacterial activity against Bacillus subtilis (MIK = 250 μg/mL) (A in Figure) . 36 Moreover, some other indolic 1,2,4-triazole derivatives exhibited good to excellent in vitro activities against Bacillus cereus (MIK = 125 μg/mL) (B in Figure) . In view of the above observations, in this study, a series of indole derivatives containing 1,2,4-triazole moiety at the 2-position were prepared in order to evaluate their in vitro antioxidant properties by determining superoxide anion formation, DPPH free radical scavenging activity, and LP on rat liver homogenate.
Antimicrobial activities of the title compounds were also tested using microdilution.
Experimental Chemistry
The chemical reagents used in synthesis were purchased from Sigma (Germany) and Aldrich (US). Thin-layer chromatography (TLC) was performed on Merck 60F254 plates. Reactions were monitored by TLC on silica gel, with detection by UV light (254 nm) or charring Dragendorff reagent. Melting points were determined with an SMP-II Digital Melting Point Apparatus and are uncorrected. Elemental analyses were performed with a LECO-932 (C, H, N, S-Elemental Analyzer) at the Faculty of Pharmacy, Ankara University.
1 H-NMR spectra were recorded in CDCl 3 or DMSO-d 6 on a Varian Mercury 400 MHz FT-NMR spectrometer using tetramethylsilane as the internal standard at the NMR facility of the Faculty of Pharmacy, Ankara University. All chemical shifts were recorded as δ (ppm). IR spectra were obtained using a Perkin Elmer Spectrum 400 FTIR/FTNIR spectrometer equipped with a Universal ATR Sampling Accessory. High resolution mass spectra data (HRMS) were collected using a Waters LCT Premier XE Mass Spectrometer operating in ESI (+) mode, also coupled to an AQUITY Ultra Performance Liquid Chromatography system.
Ethyl 1-methyl-1H -indole-2-carboxylate 1
Thionyl chloride (1.35 mL, 0.018 mol) was added dropwise with stirring to dry ethanol (25 mL) at -10
indole-2-carboxylic acid 2.5 g (0.015 mol) was then added in one portion and the mixture was stirred for 30 min at 0 • C. After stirring for a further 1 h at room temperature, the mixture was heated to reflux for 4 h and evaporated. The white crystalline powder was dissolved in dichloromethane, extracted with 5% sodium hydrogen carbonate solution and dried over sodium sulfate. 
General procedure for the preparation of 4-Benzyl/phenyl-3-(1-methyl-1H-indole-2-yl)-1H -1,2,4-triazole-5(4H )-thion derivatives 4a,b
Appropriate carbothioamides (3 mmol) (3a,b) in 20 mL of 2 N sodium hydroxide were refluxed for 7 h. The reaction mixture was cooled and then acidified to pH 6 with 1 N hydrochloric acid. The precipitate was filtered, washed with water, and recrystallized from ethanol.
4-Benzyl-3-(1-methyl-1H -indole-2-yl)-1H -1,2,4-triazole-5(4H )-thione 4a
White solid (yield 0.97 g, 96.6%). mp 236 
4-Phenyl-3-(1-methyl-1H -indole-2-yl)-1H -1,2,4-triazole-5(4H )-thione 4b
White solid (yield 0.92 g, 88.2%). mp 280 
General procedure for the preparation of 2-{4-[benzyl/phenyl-5-(substituted benzylthio)]-4H -1,2,4-triazole-3-yl}-1-methyl-1H -indole derivatives 5a-p
in 20 mL of 2 N ethanolic sodium hydroxide and appropriate benzyl bromide were heated under reflux for 7 h. The precipitate formed was cooled to room temperature, filtered, and recrystallized from ethanol.
2-{4-[Benzyl-5-(benzylthio)]-4H -1,2,4-triazole-3-yl}-1-methyl-1H -indole 5a
White solid (yield 115.3 mg, 37%). mp 159-160 
2-{4-Benzyl-5-[(4-methylbenzyl)thio]-4H-1,2,4-triazole-3-yl}-1-methyl-1H -indole 5b
White solid (yield 100 mg, 40%). mp 159-160 
2-{4-Benzyl-5-[(4-bromobenzyl)thio]-4H -1,2,4-triazole-3-yl}-1-methyl-1H -indole 5d
White solid (yield 144 mg, 37.7% 
2-{4-Benzyl-5-[(4-methoxybenzyl)thio]-4H -1,2,4-triazole-3-yl}-1-methyl-1H -indole 5f
White solid (yield 245. 
2-{4-Benzyl-5-[(4-(trifluoromethyl)benzyl)thio]-4H-1,2,4-triazole-3-yl}-1-methyl-1H -indole 5g
White solid (yield 339.5 mg, 91% 
2-{5-[(4-Methoxybenzyl)thio]-4-phenyl-4H -1,2,4-triazole-3-yl}-1-methyl-1H -indole 5n

2-{5-[(4-(Trifluoromethyl)benzyl)thio]-4-phenyl-4H-1,2,4-triazole-3-yl}-1-methyl-1H -indole 5o
2-{5-[(4-(Trifluoromethoxy)benzyl)thio]-4-phenyl-4H-1,2,4-triazole-3-yl}-1-methyl-1H -indole 5p
White solid (yield 287 mg, 74.4% 
Antioxidant and radical scavenging properties
All synthesized indole 1,2,4-triazole derivatives were tested for DPPH, superoxide radical scavenging, and anti-LP activities. All the results were compared with BHT.
Superoxide radical scavenging assay
Superoxide was generated by xanthine/xanthine oxidase and measured by the inhibition of cytochrome c reduction as described by McCord and Fridovich with some modification. 39 The incubation mixture contained 100 μL of 4 mM xanthine, 400 μL of cytochrome c, 50 mL of 50 mM phosphate buffer (pH 7.8, 1 mM EDTA), and 10 mL of the test compounds were prepared in a 96-well plate, and then 40 μL of xanthine oxidase was added to each well. The absorbance of each reaction mixture was monitored at 550 nm for 3 min. Each experiment was triplicated.
Superoxide radical scavenging activity (%) = (A control -A sample )/( A control -A blank ) × 100 (A control = the absorbance of the control, A sample = the absorbance of test sample A blank = the absorbance of blank)
DPPH radical scavenging assay
The DPPH assay was performed using test compounds, purified isolates as previously described. 40 
Assay of lipid peroxidation
The lipid peroxidation assay was performed according to the method of Mihara et al. 41 with some modification. Standard powders of gentamicin and fluconazole were obtained from the manufacturers. Stock solutions were dissolved in distilled water (gentamicin and fluconazole). All bacterial isolates were subcultured in MHA plates and incubated overnight at 37
• C and all Candida isolates were subcultured in SDA plates at 35
• C for 24-48 h. The microorganisms were passaged at least twice to ensure purity and viability.
The solutions of the newly synthesized compounds were prepared at 1256, 625, 312.5, 156.25, 78.125, 39.06, 19.5, and 9.76 μg/mL concentrations by diluting in MHB.
Bacterial susceptibility testing was performed according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) M100-S16. 42 The bacterial suspensions used for inoculation were prepared at 10 5 CFU/mL by diluting fresh cultures at McFarland 0.5 density (10 7 CFU/mL). Suspensions of the bacteria at 10 5 CFU/mL concentration were inoculated to the 2-fold diluted solution of the compounds. There were 10 4 CFU/mL bacteria in the wells after inoculations. MHB was used for diluting the bacterial suspension and for 2-fold dilution of the compound. DMSO, standard antimicrobials, pure microorganisms, and pure media were used as control wells. Bacterial inoculum was added to each well of the microdilution trays. The trays were incubated at 37
• C in a humid chamber and MIC endpoints were read after 24 h of incubation. All organisms were tested in triplicate in each run of experiments. The lowest concentration of the compound that completely inhibited macroscopic growth was determined and minimum inhibitory concentrations (MICs) are noted in Table 3 .
All Candida isolates were subcultured in SDA plates, incubated at 35
• C for 24-48 h prior to antifungal susceptibility testing, and passaged at least twice to ensure purity and viability. Susceptibility testing was performed in RPMI-1640 medium with L-glutamine buffered pH 7 with MOPS and culture suspensions were prepared through the guideline of CLSI M27-A. 43 The yeast suspensions used for inoculation were prepared at 10 4 cfu/mL by diluting fresh cultures at McFarland 0.5 density (10 6 CFU/mL). Suspensions of the yeast at 10 4 CFU/mL concentration were inoculated to 2-fold diluted solution of the compounds. There were 10 3 CFU/mL bacteria in the wells after inoculations. Yeast inoculum was added to each well of the microdilution trays. The trays were incubated at 35
• C in a humid chamber and MIC endpoints were read after 48 h of incubation. All organisms were tested in triplicate in each run of experiments. The lowest concentration of the compound that completely inhibited macroscopic growth was determined and MICs are reported in Table 3 .
Results and discussion
Chemistry
The synthetic route for the newly synthesized compounds, 1,2,4-triazolylindole derivatives (4a,b; 5a-p), is illustrated and outlined in the Scheme. Ethyl 1-methyl-1H -indole-2-carboxylate 1 was synthesized according to the literature. 
Pharmacology
Antioxidant activities
The compounds reported herein were tested for their scavenging effects of DPPH and superoxide radical, and their ability to inhibit lipid peroxidation (Table 2) . Each method is related to the generation of a different radical acting through a variety of mechanisms. The scavenging effects of synthesized compounds on DPPH radical are presented in Table 2 . Preliminary screenings of the title compounds were performed at different concentrations to determine the scavenging effects on the DPPH. Compounds 4a (IC 50 90 μM) and 4b (IC 50 65 μM), derivatives with a free 1,2,4-triazole-5(4H)-thione ring, were found to be good scavengers of DPPH radical. In these conditions the reference drug BHT showed better scavenging effects on the DPPH. Compound 5h bearing p-OCF 3 substitution on the S-benzyl ring exhibited a moderate effect on DPPH radical with an IC 50 value of 0.91 mM. Although the scavenging rates were not very pronounced, the compounds 5i, 5k, 5m, and 5n demonstrated a scavenging effect in the range of 5%-20%. The rest of the compounds had no effect on DPPH radical ( Table 2 ).
The superoxide radical scavenging activities of the compounds were also investigated by using the xhanthine/xhantine oxidase system, and there was no significant activity pattern obtained from this experiment (data are not shown). The inhibitory effect of the compounds on LP levels was examined by measuring the formation of 2-thiobarbituric acid reactive substance. As can be seen from Table 2 , the BHT inhibited LP levels by about 65% at 1 mM concentration. The compounds 4a, 4b, 5h, 5m, and 5n showed inhibitory properties on lipid peroxidation level at the same concentration. Nonsubstituted 1,2,4-triazole-5(4H)-thione ring (compounds 4a and 4b) improved inhibitory action. The most active compound is N-phenyl-3-(1-methyl-1 H -indole-2-yl)-1 H -1,2,4-triazole-5(4 H)-thion 4b; it caused 22% inhibition on LP. Compounds 5h, 5m, and 5n showed weak inhibitory effect in the range of 11%-17%. The other compounds had no inhibitory effect on LP levels.
Many studies have established beneficial effects of antioxidants that reduce the myocardial infarct size by interventions, which either attenuate the generation or reduce the effects of reactive oxygen species. The relationships between the activities, the type of substituents, and their position in the title compounds were evaluated. Introducing benzyl moiety to the triazole portion of the title compounds resulted in inactive antioxidant compound. On the other hand, the presence of a methoxy group (compound 5m and 5n) in the aromatic ring of S-benzylated derivatives showed a more positive effect on the inhibition of LP than the methyl or halogen substituted compounds. It was found that p-OCF 3 substitution on the S-benzyl ring (compound 5h) had a positive effect on DPPH radical scavenging capacity and the inhibition of LP.
Microbiology
All compounds were evaluated for their antimicrobial properties. MICs were recorded as the minimum concentration of compound that inhibits the growth of the tested microorganisms. The MIC values were determined by a microdilution method in MHB and RPMI-1640 medium for the antibacterial and antifungal assays, respectively. According to the results, the compounds showed poor activity compared with gentamicin and fluconazole. According to the data (Table 3) , all tested compounds were weakly effective against gram-negative P. aeruginosa. Compounds 4a and 4b were more effective against gram-negative bacteria and fungi than against gram-positive bacteria. Compounds 5a, 5h, and 5p showed better activity against the tested bacteria than fungi. Compound 5k showed slight antimicrobial activity against all the test microorganisms.
Conclusions
We studied the antioxidative capacity of the synthesized compounds by determining superoxide (O
•−
2 ) and DPPH radical scavenging capacity and the inhibition of LP. The results of the biological evaluation revealed that especially compounds 4a,b exhibited good scavenging effects on DPPH radical. Evaluation of activity results for scavenger effect on DPPH and inhibition of LP suggested that the free 1,2,4-triazole-5(4H)-thione ring might be important for the activity. We think that the preliminary in vitro activity results of this class of compounds might lead to further studies to develop better candidates possessing antioxidant activity. Antimicrobial evaluations of some of the presented structures against bacteria and fungi are encouraging since compound 5k showed slight antimicrobial activity against all the test microorganisms. It is considered that the solubility problem caused the generation of ineffective compounds. Designing more polar compounds may overcome solubility problems, and might achieve more active compounds. Further studies with these types of compounds are under investigation in our laboratory.
